Pelthos Therapeutics, Inc. (PTHS)

24.73 -0.27 (-1.08%) USD  |  NYAM  |  Aug 28, 16:00
24.46 -0.27 (-1.09%) After-Hours: 20:00
More

Pelthos Therapeutics Revenue Estimates for Next Fiscal Year

Revenue Estimates for Next Fiscal Year Chart

View Revenue Estimates for Next Fiscal Year for PTHS.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Revenue Estimates for Next Fiscal Year Chart
Start Trial

Historical Revenue Estimates for Next Fiscal Year Data

View and export this data back to 2025. Start Trial.
Date Value
August 24, 2026 --
August 17, 2026 --
August 14, 2026 --
August 13, 2026 --
May 15, 2026 --
May 14, 2026 --
May 08, 2026 --
April 19, 2026 --
April 13, 2026 --
April 01, 2026 --
March 25, 2026 --
March 19, 2026 --
March 06, 2026 --
March 02, 2026 --
February 26, 2026 --
January 30, 2026 --
January 23, 2026 --
Date Value
January 05, 2026 --
December 29, 2025 --
December 22, 2025 --
December 15, 2025 --
December 08, 2025 --
December 04, 2025 --
December 03, 2025 --
December 01, 2025 --
November 25, 2025 --
November 24, 2025 --
November 17, 2025 --
November 14, 2025 --
November 10, 2025 --
November 03, 2025 --
October 17, 2025 --
September 02, 2025 --
July 21, 2025 --

Revenue Estimates for Next Fiscal Year Range, Past 5 Years

View Revenue Estimates for Next Fiscal Year Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Revenue Estimates for Next Fiscal Year Benchmarks

View Revenue Estimates for Next Fiscal Year Benchmarks
Start Trial
Travere Therapeutics, Inc. Upgrade
ACADIA Pharmaceuticals, Inc. Upgrade
Alnylam Pharmaceuticals, Inc. Upgrade
Anika Therapeutics, Inc. Upgrade
Savara, Inc. Upgrade

Revenue Estimates for Next Fiscal Year Related Metrics

Revenue Estimates for Current Quarter Upgrade
Revenue Estimates for Next Quarter Upgrade
Revenue Estimates for Current Fiscal Year Upgrade
EPS Estimates for Current Quarter Upgrade
EPS Estimates for Next Quarter Upgrade
EPS Estimates for Current Fiscal Year Upgrade
EPS Estimates for Next Fiscal Year Upgrade